Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
Published on: July 7, 2023
Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors
Dorothee Eicke1,2, Anja Baigger1, Kai Schulze3
1Institute for Transfusion Medicine, Hannover Medical School, Hannover, 30625, Germany.
Abstract:
Megakaryocytes (MKs) are the precursors of platelets (PLTs) and may be used for PLT production in vivo or in vitro, as well as a source for PLT-derived growth factors. Induced pluripotent stem cells represent an unlimited cell source for the in vitro production of MKs. This study aimed at developing an effective, xeno-free and scalable system to produce high numbers of MKs. In particular, microcarrier beads-assisted stirred bioreactors were evaluated as a means of improving MK yields. This method resulted in the production of 18.7 × 107 MKs per 50 ml medium. Laminin-coated microcarriers increased MK production per iPSC by up to 10-fold. MKs obtained in this system showed typical features of mature MKs and were able to produce PLTs in vitro and in vivo. To increase safety, MKs produced in the bioreactors were irradiated; a procedure that did not affect their capability to form proPLTs and PTLs after transfusion. In vitro generated MKs represent a promising alternative to donor PLTs and open the possibility for the development of innovative MK-based cell therapies.
Insights
This study developed a scalable, xeno-free bioreactor system for producing megakaryocytes (MKs) from induced pluripotent stem cells. This method efficiently generates functional MKs for platelet production and cell therapies.
Area of Science:
- Stem cell biology
- Biotechnology
- Hematology
Background:
- Megakaryocytes (MKs) are crucial for platelet production.
- Induced pluripotent stem cells (iPSCs) offer a renewable source for MK generation.
- Existing methods for in vitro MK production face challenges in scalability and safety.
Purpose of the Study:
- To develop an effective, xeno-free, and scalable system for high-yield MK production.
- To evaluate microcarrier-assisted stirred bioreactors for enhancing MK yields.
- To assess the functionality and safety of bioreactor-generated MKs.
Main Methods:
- Utilized induced pluripotent stem cells (iPSCs) as the starting material.
- Employed microcarrier beads in stirred bioreactors for MK cultivation.
- Investigated laminin-coated microcarriers to optimize MK production.
- Irradiated generated MKs to enhance safety for therapeutic applications.
Main Results:
- Achieved production of 18.7 × 10^7 MKs per 50 ml medium.
- Laminin-coated microcarriers increased MK production from iPSCs up to 10-fold.
- Generated MKs exhibited mature characteristics and produced functional platelets in vitro and in vivo.
- Irradiation did not impair the proplatelet and platelet formation capacity of MKs.
Conclusions:
- Microcarrier-assisted stirred bioreactors provide a scalable and effective platform for xeno-free MK production.
- In vitro generated MKs are a promising alternative to donor platelets.
- These findings support the development of novel MK-based cell therapies.
Related Concept Videos
pH Scale
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Colloids and Suspensions
Support Reactions
The purpose of the supports is to prevent the translational motion of the system by applying an equal and opposite force and to prevent the system's rotation by applying...
Scaling
Support Reactions in Three Dimensions
Ball and Socket Joint is one of the supports allowing free rotation about any axis. This freedom of rotation is...

